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A population-based study has identiﬁed bacteraemia as a
leading cause of death in America. In this issue of CMI, the
systematic collection of cases of bacteraemia and fungaemia
cases from a Canadian electronic database shows that 240
patients per year, in the observed population, had died fol-
lowing an episode of bacteraemia, representing an incidence
of 20 per 100 000 inhabitants [1]. More than half of the bac-
teraemias were healthcare-associated or nosocomial. In the
USA, a study performed in 2009 by the CDC ranked septi-
caemia as the tenth most common cause of death, with an
incidence of 11.4 per 100 000 inhabitants (http://www.cdc.
gov/nchs/fastats/lcod.htm). Moreover, when researchers from
the University of Pennsylvania focused on the causes of
death from catheter-associated bacteraemia, they showed an
incidence of 10.7 per 100 000 people, representing the 12th
most common cause of death in the USA [2]. In Europe, a
study performed in Denmark, relying on systematic analyses
of databases, evaluated bacteraemia-related mortality at 14
per 100 000 inhabitants per year [3], half of the cases being
community-acquired. If the American data, and particularly
those of this article [1], are comparable with those for Eur-
ope, such a mortality of 20 per 100 000 inhabitants per year
would make bacteraemia the fourth leading cause of mortal-
ity (following cardiac diseases, lung and larynx cancer com-
bined and cerebrovascular diseases) ex aequo with cancers of
the colon and haematopoietic cancer, above diabetes, breast
cancer and suicides. Indeed, this is a serious public health
target, as it is possible to rapidly obtain a decrease in this
mortality, as recently described in the USA (http://www.
cdc.gov/mmwr/preview/mmwrhtml/mm6008a4.htm?s_cid=mm
6008a4_w). It appears that one of the European priorities
should be to have an objective evaluation of the incidence
and mortality of bacteraemia, in particular of that related to
healthcare, eventually by using computer algorithms [4]. This
is a prerequisite for any efﬁcient ﬁght against it.
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